SUPT7L Antikörper (AA 364-414)
Kurzübersicht für SUPT7L Antikörper (AA 364-414) (ABIN1938009)
Target
Alle SUPT7L Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 364-414
-
Spezifität
- Region between residue 364 and 414 of human Suppressor of Ty 7-like using the numbering given in entry NP_055675.1 (GeneID 9913).
-
Aufreinigung
- Immunoaffinity purified
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: IF (1:50 - 1:500), IHC, IHC-P (1:100 - 1:500), IP (2 - 5 μg/mg lysate), WB (1:2000 - 1:10000)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Human controls: Breast Carcinoma, Colon Carcinoma. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Tris-buffered saline, 0.1 % BSA, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8°C for up to 1 year.
-
Haltbarkeit
- 12 months
-
-
- SUPT7L (Suppressor of Ty 7 Like (SUPT7L))
-
Andere Bezeichnung
- SPT7L / SUPT7L
-
Hintergrund
-
Name/Gene ID: SUPT7L
Synonyms: SUPT7L, Adenocarcinoma antigen ART1, SPT7L, STAGA complex 65 subunit gamma, STAF65(gamma), STAF65G, Suppressor of Ty 7-like, SUPT7H, STAF65gamma, STAGA complex 65 gamma subunit, KIAA0764, STAF65 -
Gen-ID
- 9913
-
Pathways
- Maintenance of Protein Location
Target
-